Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stent, AAA Problems Top Adverse Events In CDRH Annual Report

This article was originally published in The Gray Sheet

Executive Summary

Thrombus linked to coronary stents and aneurysm fatalities in patients with endovascular grafts were among top adverse events reported to the device center last fiscal year, CDRH reveals in its long-awaited FY 2003 annual report

You may also be interested in...

Recalled Cochlear Implant Positioner Increases Meningitis Risk – NEJM Study

Advanced Bionics' decision to remove the electrode positioner from its Clarion cochlear implants last summer is supported by a study in the July 31 issue of The New England Journal of Medicine

CDRH To Start New Year By Expanding Alternative Summary Reporting

Malfunction reports for ventilators and surgical staplers will be eligible for alternative summary reporting (ASR) in early 2001, FDA Center for Devices and Radiological Health officials predict.

Aducanumab Review: Looking For Precedents – Long Ago And Far Afield

The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts